Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy.
A patient with immune-mediated thrombocytopenia (ITP) and chronic hepatitis C virus (HCV) infection for 11 years was given immunosuppressive treatment because of an activation of his ITP. After 6 weeks of treatment with cyclophosphamide, cyclosporin A and cortisone the patient decided not to continue taking his medication. One month later he was readmitted to hospital due to fever, cough and jaundice. Clinical investigation revealed his condition to be caused by an activation of his HCV infection. It is concluded that, in parallel to the situation in hepatitis B, immunosuppressive treatment of patients with HCV infection may lead to increased viral replication, resulting in severe liver damage when immunocompetence is regained.
Gruber
A
A
Department of Internal Medicine, Karolisnka Hospital, Stockholm, Sweden.
Lundberg
L G
LG
Björkholm
M
M
D000328:Adult; D006526:Hepatitis C / Q000209:etiology*; D006521:Hepatitis, Chronic / Q000209:etiology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D008297:Male; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000628:therapy*; D014775:Virus Activation / Q000276:immunology*
D016756:Immunoglobulins, Intravenous